Oracle Investment Management Boosted Its Contrafect (CFRX) Position by $718,385; Third Point Reinsurance LTD (TPRE) Shares Declined While Kelso & Company LP Trimmed Holding

May 19, 2018 - By wolcottdaily

ContraFect Corporation (NASDAQ:CFRX) Logo

Kelso & Company Lp decreased its stake in Third Point Reinsurance Ltd. (TPRE) by 60% based on its latest 2017Q4 regulatory filing with the SEC. Kelso & Company Lp sold 15.00 million shares as the company’s stock declined 7.89% with the market. The hedge fund held 10.00 million shares of the property-casualty insurers company at the end of 2017Q4, valued at $146.50 million, down from 25.00 million at the end of the previous reported quarter. Kelso & Company Lp who had been investing in Third Point Reinsurance Ltd. for a number of months, seems to be less bullish one the $1.37 billion market cap company. The stock increased 1.52% or $0.2 during the last trading session, reaching $13.4. About 650,957 shares traded or 17.93% up from the average. Third Point Reinsurance Ltd. (NYSE:TPRE) has risen 19.15% since May 19, 2017 and is uptrending. It has outperformed by 7.60% the S&P500.

Oracle Investment Management Inc increased its stake in Contrafect Corp (CFRX) by 32.92% based on its latest 2017Q4 regulatory filing with the SEC. Oracle Investment Management Inc bought 718,385 shares as the company’s stock rose 45.45% while stock markets declined. The hedge fund held 2.90 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.93 million, up from 2.18 million at the end of the previous reported quarter. Oracle Investment Management Inc who had been investing in Contrafect Corp for a number of months, seems to be bullish on the $133.32 million market cap company. The stock decreased 3.72% or $0.07 during the last trading session, reaching $1.81. About 75,053 shares traded. ContraFect Corporation (NASDAQ:CFRX) has declined 21.95% since May 19, 2017 and is downtrending. It has underperformed by 33.50% the S&P500.

Since March 20, 2018, it had 0 buys, and 1 sale for $1.47 million activity.

Investors sentiment increased to 3.26 in 2017 Q4. Its up 1.02, from 2.24 in 2017Q3. It is positive, as 12 investors sold TPRE shares while 22 reduced holdings. 34 funds opened positions while 77 raised stakes. 151.48 million shares or 90.11% more from 79.68 million shares in 2017Q3 were reported. Credit Suisse Ag holds 0% in Third Point Reinsurance Ltd. (NYSE:TPRE) or 103,812 shares. Indexiq Limited Liability Company invested in 0.06% or 116,428 shares. Prudential Financial Incorporated invested in 172,943 shares. 1.35M are owned by Robeco Institutional Asset Management Bv. Moreover, Bank Of New York Mellon Corp has 0% invested in Third Point Reinsurance Ltd. (NYSE:TPRE). 73,037 were reported by Zacks Invest. Hotchkis Wiley Mgmt Llc owns 106,651 shares or 0.01% of their US portfolio. Insight 2811 has invested 0.56% of its portfolio in Third Point Reinsurance Ltd. (NYSE:TPRE). Deutsche Bank Ag holds 493,755 shares or 0% of its portfolio. Guggenheim Cap Limited Liability Company owns 0.01% invested in Third Point Reinsurance Ltd. (NYSE:TPRE) for 153,503 shares. James Investment invested in 100,700 shares or 0.05% of the stock. Systematic Financial Management LP stated it has 462,885 shares. Jefferies Gru has invested 0% of its portfolio in Third Point Reinsurance Ltd. (NYSE:TPRE). Dean Invest Assoc Ltd Limited Liability Company reported 0.7% stake. Pnc Fincl Services Grp Incorporated reported 427 shares.

More news for Third Point Reinsurance Ltd. (NYSE:TPRE) were recently published by: Seekingalpha.com, which released: “Third Point Reinsurance’s (TPRE) CEO Rob Bredahl on Q1 2018 Results – Earnings Call Transcript” on May 13, 2018. Streetinsider.com‘s article titled: “Third Point Reinsurance Ltd. (TPRE) Misses Q1 EPS by 3c” and published on May 09, 2018 is yet another important article.

Among 6 analysts covering Third Point Reinsurance (NYSE:TPRE), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Third Point Reinsurance had 16 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, May 8 by Keefe Bruyette & Woods. The company was maintained on Monday, December 4 by Keefe Bruyette & Woods. Compass Point maintained the stock with “Buy” rating in Wednesday, September 2 report. The rating was maintained by Bank of America with “Buy” on Tuesday, April 3. The company was maintained on Friday, September 8 by Keefe Bruyette & Woods. Morgan Stanley maintained it with “Equal-Weight” rating and $17 target in Friday, November 10 report. The firm earned “Outperform” rating on Friday, May 11 by Wood. The firm earned “Buy” rating on Tuesday, October 10 by Keefe Bruyette & Woods. The stock of Third Point Reinsurance Ltd. (NYSE:TPRE) earned “Buy” rating by Keefe Bruyette & Woods on Thursday, May 10. Wood maintained Third Point Reinsurance Ltd. (NYSE:TPRE) on Thursday, October 1 with “Market Perform” rating.

Analysts await Third Point Reinsurance Ltd. (NYSE:TPRE) to report earnings on August, 1. They expect $0.45 EPS, down 36.62% or $0.26 from last year’s $0.71 per share. TPRE’s profit will be $46.01M for 7.44 P/E if the $0.45 EPS becomes a reality. After $-0.26 actual EPS reported by Third Point Reinsurance Ltd. for the previous quarter, Wall Street now forecasts -273.08% EPS growth.

Among 3 analysts covering ContraFect (NASDAQ:CFRX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. ContraFect had 5 analyst reports since December 31, 2015 according to SRatingsIntel. The stock has “Outperform” rating by William Blair on Wednesday, September 28. The stock of ContraFect Corporation (NASDAQ:CFRX) earned “Buy” rating by Maxim Group on Friday, July 22. The stock of ContraFect Corporation (NASDAQ:CFRX) earned “Neutral” rating by Roth Capital on Tuesday, May 10. The firm earned “Buy” rating on Thursday, December 31 by Maxim Group.

Oracle Investment Management Inc, which manages about $877.33M and $503.31 million US Long portfolio, decreased its stake in Pacific Biosciences Calif In (NASDAQ:PACB) by 233,080 shares to 8.45M shares, valued at $22.32 million in 2017Q4, according to the filing. It also reduced its holding in Mazor Robotics Ltd (NASDAQ:MZOR) by 927,024 shares in the quarter, leaving it with 1.29 million shares, and cut its stake in Accuray Inc (NASDAQ:ARAY).

Third Point Reinsurance Ltd. (NYSE:TPRE) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 wolcottdaily

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: